Glimperide, Metformin & Pioglitazone Combination (Extended Release)

Send Inquiry

Request To Call Back

Glimperide, Metformin & Pioglitazone Combination (Extended Release)

Get a Price/Quote

Glimperide, Metformin & Pioglitazone Combination (Extended Release) Specification

Drug Type
Specific Drug

Ingredients
Glimepiride 1 mg + Metformin 500 mg + Pioglitazone 15 mg (ER) Glimepiride 2 mg + Metformin 500 mg + Pioglitazone 15 mg (ER)

Physical Form
Tablets

Function
Other

Recommended For
Management of Type 2 diabetes (NIDDM)

Suitable For
Adults, Aged Person

Glimperide, Metformin & Pioglitazone Combination (Extended Release) Trade Information

Payment Terms
Western Union, Cash in Advance (CID), Cheque, Cash Advance (CA)

Sample Policy
Sample costs shipping and taxes has to be paid by the buyer

Packaging Details
ALu-Alu,10*10 Pack

Main Export Market(s)
Western Europe, Australia, Eastern Europe, Middle East, South America, Asia, Central America, North America, Africa

Main Domestic Market
All India

Certifications
WHO-GMP

About Glimperide, Metformin & Pioglitazone Combination (Extended Release)

Glimperide, Metformin & Pioglitazone Combination (Extended Release) Tablets are specifically designed for effective management of Type 2 Diabetes Mellitus (NIDDM). Available in two formulations - Glimepiride 1 mg + Metformin 500 mg + Pioglitazone 15 mg (ER) and Glimepiride 2 mg + Metformin 500 mg + Pioglitazone 15 mg (ER) - these tablets combine three active ingredients that work synergistically to help control blood sugar levels in adults and older individuals. Glimepiride stimulates the pancreas to produce insulin, Metformin decreases glucose production in the liver, and Pioglitazone improves insulin sensitivity. The extended-release formulation ensures a sustained effect throughout the day for better glycemic control. These tablets are recommended for diabetic patients seeking reliable and comprehensive management of their condition.

FAQs of Glimperide, Metformin & Pioglitazone Combination (Extended Release):

Q: What is the primary use of this medication?

A: It is used for the management of Type 2 Diabetes Mellitus (NIDDM).

Q: What are the active ingredients in this product?

A: The tablets contain Glimepiride, Metformin, and Pioglitazone in specified doses.

Q: Who is suitable to use these tablets?

A: These tablets are suitable for adults and elderly individuals diagnosed with Type 2 Diabetes.

Q: Why is it an extended-release formulation?

A: The extended-release formulation ensures sustained blood sugar control over a longer period.

Q: Are these tablets designed for monotherapy or combination therapy?

A: These tablets are intended for combination therapy to address diabetes from multiple pathways.

Tell us about your requirement

Price:

Quantity

Select Unit

50
100
200
250
500
1000+

Additional detail

Mobile number

More Products in Diabetic Tablets Category

Diabetic Tablets

Suitable For : Adults

Drug Type : Drug Solutions

Function : Antibiotic Medicine

Physical Form : Tablets

Get a Price/Quote

Glimepride 2 mg & Pioglitazone 30 mg (SR)

Suitable For : Adults, Aged Person

Drug Type : Specific Drug

Function : Other

Physical Form : Tablets

Ingredients : Glimepride 2 mg + Pioglitazone 30 mg (SR)

Recommended For : Management of Type 2 diabetes (NIDDM)

Get a Price/Quote

Tenegliptin with Metformin Combination

Suitable For : Adults, Aged Person

Drug Type : Specific Drug

Function : Other

Physical Form : Tablets

Ingredients : Auctista20 : Tenegliptin20 mg, Auctista M 500 : Tenegliptin20 mg + Metformin 500 mg SR, AuctistaM1000 :Tenegliptin20 mg + Metformin 1000 mg SR

Recommended For : Type 2 Diabetes Mellitus

Get a Price/Quote

Calcium Dobisilate 500 mg

Suitable For : Adults, Aged Person

Drug Type : Specific Drug

Function : Other

Physical Form : Tablets

Ingredients : Calcium Dobisilate 500 mg

Recommended For : Diabetic retinopathy and Glaucoma,Diabetic Microangiopathy

Get a Price/Quote